| Recruiting | ETHAN - ET for Male BC NCT05501704 | Jose Pablo Leone | Phase 2 |
| Terminated | Testosterone & Tamoxifen Trial NCT05156606 | University Medical Center Groningen | N/A |
| Completed | EORTC Quality of Life Measurement in Males With Breast Cancer NCT07455110 | Helios University Hospital Wuppertal | — |
| Completed | Pilot Study of Paclitaxel Plus Pembrolizumab in Metastatic HER2-Negative Breast Cancer NCT03018080 | Wake Forest University Health Sciences | Phase 2 |
| Unknown | Silent Breast Cancer A Study of the Disease Prevalence Held by Imaging Guided Biopsies in Autopsy Specimens NCT02480933 | Centro Hospitalar Lisboa Ocidental | N/A |
| Completed | CYP17 Lyase and Androgen Receptor Inhibitor Treatment With Seviteronel Trial (INO-VT-464-006; NCT02580448) NCT02580448 | Innocrin Pharmaceutical | Phase 1 / Phase 2 |
| Completed | Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Pos NCT02060253 | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Terminated | Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast Cancer NCT01938833 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Phase 1 / Phase 2 |
| Completed | Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot B NCT02013492 | William Carson | EARLY_Phase 1 |
| Unknown | Understanding Male Breast Cancer: Salah Azaïz Cancer Institute Experience NCT03240510 | Salah Azaïz Cancer Institute | — |
| Completed | Carboplatin, Gemcitabine Hydrochloride, and Mifepristone in Treating Patients With Advanced Breast Cancer or R NCT02046421 | University of Chicago | Phase 1 |
| Completed | Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer NCT01869764 | Wake Forest University Health Sciences | Phase 2 |
| Terminated | Lapatinib Ditosylate and Radiation Therapy in Treating Patients With Locally Advanced or Locally Recurrent Bre NCT01868503 | Stanford University | Phase 2 |
| Completed | Phase 1b/2 Trial Using Lapatinib, Everolimus and Capecitabine for Treatment of HER-2 Positive Breast Cancer Wi NCT01783756 | Jonsson Comprehensive Cancer Center | Phase 1 / Phase 2 |
| Completed | 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis NCT01806675 | Sanjiv Sam Gambhir | Phase 1 / Phase 2 |
| Withdrawn | A Pilot Study of Irinotecan in Patients With Breast Cancer and CNS Metastases NCT01939483 | University of California, Irvine | N/A |
| Terminated | Vaccine Therapy in Treating Patients With Stage IV Hormone Receptor Positive Breast Cancer NCT01729884 | University of Washington | Phase 2 |
| Completed | Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy NCT01720602 | University of Washington | N/A |
| Terminated | Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Meta NCT01705340 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Tamoxifen +/- GnRH Analogue vs Aromatase Inhibitor + GnRH Analogue in Male Breast Cancer Patients NCT01638247 | GBG Forschungs GmbH | Phase 3 |
| Completed | Vaccine Therapy in Treating Patients With Previously Treated Stage II-III HER2-Positive Breast Cancer NCT01632332 | Mayo Clinic | Phase 1 |
| Withdrawn | Ex Vivo-Expanded HER2-Specific T Cells and Cyclophosphamide After Vaccine Therapy in Treating Patients With HE NCT01219907 | University of Washington | Phase 1 |
| Completed | Nab-paclitaxel (Abraxane) With or Without Mifepristone in Patients With Advanced Breast Cancer NCT01493310 | University of Chicago | Phase 1 |
| Terminated | FDG PET and DCE-MRI in Predicting Response to Treatment in Patients With Breast Cancer NCT01931709 | University of Washington | N/A |
| Unknown | Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer Patients NCT01372579 | Northwestern University | Phase 2 |
| Terminated | Neo-adjuvant Therapy With Anastrozole Plus Pazopanib in Stage II and III ER+ Breast Cancer NCT01394211 | University of Arizona | Phase 2 |
| Completed | Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER NCT01355393 | University of Washington | Phase 1 / Phase 2 |
| Completed | Finasteride (MK-0906) and Male Breast Cancer - A Register-Based Nested Case-Control Study (MK-0906-162/2003.02 NCT01703520 | Organon and Co | — |
| Completed | Heavy Metal Exposure in Predicting Peripheral Neuropathy in Patients With Stage I-III Breast Cancer Undergoing NCT01982591 | Fox Chase Cancer Center | — |
| Completed | Paclitaxel and Bavituximab in Treating Patients With HER2-Negative Metastatic Breast Cancer NCT01288261 | University of Arizona | Phase 1 |
| Completed | Akt Inhibitor MK2206 in Combination With Lapatinib Ditosylate in Patients With Advanced or Metastatic Solid Tu NCT01245205 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor Therapy NCT01153672 | University of Washington | N/A |
| Terminated | Endoscopic Breast Surgery in Treating Patients With Breast Cancer NCT01222377 | University of Southern California | N/A |
| Completed | Veliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast NCT01104259 | University of Washington | Phase 1 |
| Terminated | Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced, Metastatic, o NCT01151449 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors NCT01155258 | University of Southern California | Phase 1 |
| Completed | RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors NCT01158274 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Ixabepilone and Vorinostat in Treating Patients With Metastatic Breast Cancer NCT01084057 | City of Hope Medical Center | Phase 1 |
| Withdrawn | Breast-Conserving Surgery Followed by Radiation Therapy With MRI-Detected Stage I or Stage II Breast Cancer NCT01100489 | Case Comprehensive Cancer Center | Phase 2 |
| Completed | Vaccine Therapy and 1-MT in Treating Patients With Metastatic Breast Cancer NCT01042535 | H. Lee Moffitt Cancer Center and Research Institute | Phase 1 / Phase 2 |
| Completed | Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer NCT01037790 | Abramson Cancer Center at Penn Medicine | Phase 2 |
| Terminated | Cediranib Maleate and Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung NCT00937482 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer NCT01706432 | University of Chicago | — |
| Completed | Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast Cancer NCT00821964 | University of Washington | Phase 2 |
| Completed | Vaccine Therapy in Treating Patients With Stage IV Breast Cancer NCT00791037 | University of Washington | Phase 1 / Phase 2 |
| Completed | Saracatinib in Treating Patients With Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed By S NCT00559507 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patie NCT00513695 | University of Washington | Phase 2 |
| Completed | Tipifarnib and Combination Chemotherapy in Treating Patients With Stage II or Stage III Breast Cancer NCT00470301 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | Vorinostat and Trastuzumab in Treating Patients With Metastatic or Locally Recurrent Breast Cancer NCT00258349 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | Phase I-II Study of Vorinostat, Paclitaxel, and Bevacizumab in Metastatic Breast Cancer NCT00368875 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | AFP464 in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery NCT00348699 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Doxorubicin Hydrochloride Liposome, Cyclophosphamide, and Trastuzumab in Treating Patients With Stage IV Breas NCT00331552 | University of Washington | Phase 1 / Phase 2 |
| Completed | Dexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and Vomiting in NCT00343863 | University of Washington | N/A |
| Completed | Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer NCT00119262 | National Cancer Institute (NCI) | Phase 2 |
| Completed | A Phase II Study of AZD2171 in Breast Cancer Stage IV (10006202) NCT00244881 | National Cancer Institute (NCI) | Phase 2 |
| Completed | ONTAK® in Treating Patients With Advanced Breast Cancer That Did Not Respond to Previous Treatment NCT00425672 | University of Washington | Phase 1 / Phase 2 |
| Terminated | Suberoylanilide Hydroxamic Acid in Treating Patients With Progressive Stage IV Breast Cancer NCT00132002 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Trastuzumab, Ixabepilone, and Carboplatin in Treating Patients With HER2/Neu-Positive Metastatic Breast Cancer NCT00077376 | National Cancer Institute (NCI) | Phase 2 |
| Completed | FR901228 in Treating Patients With Metastatic Breast Cancer NCT00098397 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Lapatinib in Treating Brain Metastases in Patients With Stage IV Breast Cancer and Brain Metastases NCT00098605 | National Cancer Institute (NCI) | Phase 2 |
| Terminated | 3-AP and Gemcitabine in Treating Patients With Refractory Metastatic Breast Cancer NCT00095888 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Sorafenib in Treating Patients With Metastatic Breast Cancer NCT00096434 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors NCT00089362 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Vaccine Therapy in Treating Patients Receiving Trastuzumab For HER2-Positive Stage IIIB-IV Breast Cancer NCT00343109 | University of Washington | Phase 2 |
| Completed | GTI-2040 and Capecitabine in Treating Patients With Metastatic Breast Cancer NCT00068588 | National Cancer Institute (NCI) | Phase 2 |
| Terminated | Vaccine Therapy in Treating Patients With Metastatic Breast Cancer NCT00071942 | National Cancer Institute (NCI) | Phase 1 |
| Terminated | Oblimersen Plus Doxorubicin and Docetaxel in Treating Patients With Metastatic or Locally Advanced Breast Canc NCT00063934 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | Imatinib Mesylate in Treating Patients With Metastatic Breast Cancer NCT00045188 | National Cancer Institute (NCI) | Phase 2 |
| Terminated | Trastuzumab and Flavopiridol in Treating Patients With Metastatic Breast Cancer NCT00039455 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Trastuzumab and Gefitinib in Treating Patients With Metastatic Breast Cancer NCT00024154 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction NCT00030498 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Decitabine in Treating Patients With Advanced Solid Tumors NCT00030615 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors NCT00028535 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer NCT00028496 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Bevacizumab Plus Vinorelbine in Treating Patients With Stage IV Breast Cancer NCT00017394 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Trastuzumab and Interleukin-2 in Treating Patients With Metastatic Breast Cancer NCT00006228 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Rebeccamycin Analogue in Treating Women With Stage IIIB or Stage IV Breast Cancer NCT00005817 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu NCT00004074 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in NCT00003199 | Fred Hutchinson Cancer Center | Phase 2 |